factual

Direct-to-consumer GLP-1 pricing eliminated list-to-net gap

When pharma sold GLP-1s direct to consumers, the list-to-net gap was eliminated by removing PBMs and insurers, and prices fell from about $1,300 list to about $149 cash, while drugmakers still earned more gross profit.

factualpending

Speaker

Zach Reitano

Evidence Quote

“That list-to-net gap gets entirely eliminated. When people are pointing fingers between insurance companies and PBMs and pharma and who's to blame, they go direct. You remove the PBM and insurance company entirely.”

Source

Zach Reitano - Building Ro and Why Healthcare Should Be 50% of GDP - [Invest Like the Best, EP.500]— Invest Like the Best
Created: 11/17/2026, 7:03:01 AM

Your notes

Loading notes...